ManagementMeet the management team of NBCD
Sara Daugaard Popik
Sara is the Managing Director of NBCD and has been with the company since 2011. She holds a master’s in Pharmaceutical Science (M.Sc. Pharm) from University of Copenhagen, Denmark, and started her career in NBCD as a Clinical Research Associate.
Sara has held many positions within Study Operations through the years and before shifting her focus to the management of the organization, Sara was involved in numerous clinical studies with a total of more than 15,000 patients within the therapeutic fields of osteoarthritis and osteoporosis.
Sara headed the successful expansion of the Clinical Operations Department and the integration of NBCDs Quality Management System, including implementation of Risk-Based Monitoring and various computerized systems.
Now, Sara is actively focusing on running a smooth organization with very low staff turnover, while simultaneously ensuring successful conduction of the clinical trials.
Asger Bering Kristensen
Asger joined the company in 2023 as Executive Director, Project Delivery. He holds a master's in pharmaceutical science (M.Sc.Pharm) from the University of Copenhagen and a Diploma in Pharmaceutical Medicince from the University of Basel.
For 20+ years, Asger has held management positions across small to mid-size pharma and biotech, most recently as VP Clinical Operations at UNION therapeutics A/S.
As Executive Director, Asger heads the NBCD Management team and as such responsible for successful operational delivery of clinical trials.
Anne Bo Folin
Anne is Associate Director, Clinical Operations in NBCD and has been with the company since 2012. She holds a master’s in Medicine with Industrial Specialization, Translational Medicine (Cand.Scient.Med) from University of Aalborg, Denmark, and started her career in clinical research in 2011.
Anne has had various responsibilities within Study Operations through the years and is now in charge of the Clinical Trial- and Document Systems Management groups. She is passionate about the facilitation and management of clinical trials and have been involved in several clinical studies throughout the years gaining experience within osteoarthritis, osteoporosis and rheumatoid arthritis.
Anne played an integral role in the development NBCDs Risk-Based Monitoring Approach, and she has a curios approach to all new challenges. Furthermore, she was an important part of the team through the expansion of the Clinical Operations Department.
Kalliroi is Associate Director, Clinical Operations in NBCD and has been with the company since 2015. She holds a 4-year degree in Biology from Aristotle University of Thessaloniki, Greece, and started her career in clinical research back in 2010.
Before joining NBCD, Kalliroi gained experience from both small and big CROs, as well as big pharmaceutical companies – this experience gave her powerful insights, which she now uses in her work with study planning.
The main focus for Kalliroi is sponsor satisfaction, upholding timelines and efficiency throughout the team. Her key interests are recruitment optimization, patient centricity and finding cost-effective solutions for successful clinical trial conduct.
As the Manager of the Clinical Research Associates group, her goal is to create value for the employees and continue making NBCD a great and meaningful place to work.
Bodil is Associate Director, Regulatory Affairs & Safety in NBCD and has been with the company since 2011. She holds a master’s in Pharmaceutical Science (M.Sc. Pharm) from University of Copenhagen, Denmark, and started her career in clinical research in 2009.
Bodil started out within Safety and later expanded her area of responsibility to the Regulatory field as well. Through the years, she has overseen world-wide clinical trial application submissions and safety reporting for numerous clinical trials within therapeutic areas such as osteoarthritis, osteoporosis and rheumatoid arthritis.
As the Manager of the Regulatory Affairs & Safety group, she works toward delivering high-quality documentation, ensuring as smooth and quick clinical trial application approval, as well as ensuring safety reporting in accordance with all country specific requirements.
Kamilla is Associate Director, Data Management in NBCD and has been with the company since 2017. She holds a master’s in Molecular Biology and a Ph.D. degree in Science from Aarhus University, Denmark, and she started her career in clinical research back in 2010.
Kamilla has 13+ years of research-, data management-, and supervisor experience from both NBCD and academia – giving her both scientific and practical experience. She has primarily worked within the fields of osteoarthritis and rheumatoid arthritis, and is motivated by advancing the field of health science.
As a Manager, Kamilla leads with a great amount of trust and supports her employees to succeed both individually and as a team. She values employees that show initiative, claim responsibility, and take ownership for their tasks and the team’s wellbeing. She puts emphasis on thorough training during onboarding, as well as integration into the Data Management team.
Anna is Associate Director, Clinical Processes in NBCD and has been with the company since 2018. She holds a master’s in Pharmaceutical Science (M.Sc. Pharm) from University of Copenhagen, Denmark. She started her career in clinical research in 2016, in the hospital pharmacy taking care of IMP for oncology trials as a delegated QP.
Anna enjoys working in different teams and has been holding various positions within NBCD – giving her a broad knowledge of different groups’ perspective on project management, ICH-GCP and the processes surrounding clinical trial conduct.
Anna brings a unique insight in how different procedures and processes are working during study conduct, providing important inputs for optimization. This have supported Annas passion for optimizing procedures and processes, to ensure that they are aligned with the current requirements in the field, while still being relevant and effective for the staff working with them.